Welcome to ExCellThera’s Media Centre.

If you are looking for an expert to comment on the scale up of blood stem cells for therapeutic use, or the technologies developed by ExCellThera, we can help you. ExCellThera’s scientific and leadership team comprises experts in their fields and they can conduct interviews in English and French. Consult the section about Our team here.

If you are a member of the media, please feel free to use the information you find on this site in your stories. Please acknowledge ExCellThera as the original source. We also encourage you to provide your audience with ExCellThera’s Website address:

To learn more about ExCellThera or to schedule an interview, please contact:
Phone: 647-309-1830

News Releases

ExCellThera wins 2017 MaRS HealthKick Challenge Investor Pitch Competition

Clinical Stage Biotechnology Company Receives Prize in the Pharma & Biotech Category April 12, 2017 (Montreal, QC and Toronto, ON) – ExCellThera’s win at the 2017 MaRS HealthKick Challenge is validation from the investor community that ExCellThera is doing exciting work that will have an impact on health care and the treatment of patients with […]

Read more »

ExCellThera Announces Initiation of Clinical Trial for Cancer Patients

Phase I/II Trial of ECT-100 to begin in early 2016 at multiple Canadian sitesDecember 21, 2015 (Montreal, QC and Toronto, ON) – ExCellThera is pleased to announce that Health Canada has approved the initiation of a Phase I/II clinical trial of its lead product, ECT-100, for the expansion of hematopoietic stem cells (HSCs). The trial, […]

Read more »

New company will benefit patients undergoing transplants for leukemias

IRICoR and CCRM partner to launch ExCellThera to produce high number of blood stem cells required for human transplantsJune 15, 2015 (MONTREAL, Quebec and TORONTO, Ontario) – Patients suffering from acute myeloid leukemia (AML), who require stem cell transplantation as part of their treatment, may now benefit from a new best-in-class process that improves the […]

Read more »

ExCellThera in the News

Forging Partnerships In Regenerative Medicine Helps Make Canada A World Leader

Forging Partnerships In Regenerative Medicine Helps Make Canada A World Leader. Mediaplanet, April, 2017.

ExCellThera wins 2017 MaRS HealthKick challenge investor pitch competition

ExCellThera wins 2017 MaRS HealthKick challenge investor pitch competition. Biotechnology Focus, April 18, 2017.

A multitiered approach to stem cell discoveries

A multitiered approach to stem cell discoveries. MaRS Magazine, November 4, 2016. 

The success of ExCellThera highlighted in Bio Business

Returning to form: New funding gives hope for 10 new therapies over the next 10 years Bio Business, Sept./Oct. 2015. 

ExCellThera in BioWorld Today

In the Clinic: ExCellThera. BioWorld Today (page 12), December 22, 2015.

U of T Expands Research Facilities in New Partnership with MaRS

U of T Expands Research Facilities in New Partnership with MaRS. Faculty of Medicine, University of Toronto, September 2, 2015.

Banking on cord blood

Banking on cord blood. Ontario Institute for Regenerative Medicine 

ExCellThera in the ten companies to watch – Stem Cell Assays

Ten companies to watch. Stem Cell Assays, July 1, 2015.

BiotechFinances: ExCellThera to transform stem cell transplantation therapies

Québec: ExCellThera veut transformer la greffe de cellules souches. BiotechFinances, June 22, 2015 [French only]

ExCellThera © 2016. All Rights Reserved.